Dominik Escher
Gründer bei CDR-Life Inc.
Ursprung des Netzwerks ersten Grades von Dominik Escher
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
University of Zurich
99
| College/University | Other Consumer Services | 99 |
Swiss Federal Institute of Technology
73
| College/University | Other Consumer Services | 73 |
Eyevensys SAS
 Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.
10
| Holding Company | Miscellaneous Commercial Services | 10 |
CDR-Life Inc.
 CDR-Life Inc. BiotechnologyHealth Technology CDR-Life Inc. is a Swiss biotherapeutics company that develops novel immunotherapies to target the power of the immune system specifically to tumor cells. CDR-Life is based in Schlieren, Switzerland, and was founded in 2017 by Leonardo Borras, Christian Leisner, Dominik Escher, Rouven Bingel-Erlenmeyer, and Konstantin von Schulthess. The company's proprietary antibody platform targets intracellular tumor antigens presented on the major histocompatibility complex (MHC) with high affinity and specificity, which allows them to develop a pipeline of first-in-class therapeutics across a broad range of solid tumors. The company is backed by leading cross-Atlantic investors and has an existing collaboration and licensing agreement with Boehringer Ingelheim for a novel antibody fragment therapy to treat macular degeneration. Christian Leisner has been the CEO since 2017.
8
| Holding Company | Biotechnology | 8 |
Araris Biotech AG
 Araris Biotech AG Miscellaneous Commercial ServicesCommercial Services Araris Biotech AG engages in the development and research of an antibody-drug conjugate (ADC) linker technology. It focuses on the production of ADCs. Its linker platform enables the attachment of payload to off the shelf antibodies without the need of antibody engineering. The company was founded by Philipp Spycher, Isabella Attinger-Toller, and Dragan Grabulovski and is headquartered in Z?rich, Switzerland.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
TOPADUR Pharma AG
 TOPADUR Pharma AG Pharmaceuticals: MajorHealth Technology TOPADUR Pharma AG is a Swiss-based biotech company located in Schlieren. TOPADUR is a patient-oriented biotech company that aims to enhance the quality of life through cutting-edge research. The private company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, which corrects locally cgmp levels. These compounds target high medical needs and can be used to treat several ageing-related diseases resulting from insufficient local blood-circulation. The company was founded in 2015 by Reto Naef, who has been the CEO since then.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Pureos Partners AG
 Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland.
5
| Operating Division | Investment Managers | 5 |
NovaGo Therapeutics AG
 NovaGo Therapeutics AG Pharmaceuticals: MajorHealth Technology NovaGo Therapeutics AG is a biotechnology start-up company, which engages in the development and manufacture of human antibody products. It focuses on cerebral stroke and spinal cord injury to stimulate nerve repair and regeneration. Its offering includes recombinant human monoclonal antibodies targeting the nerve outgrowth inhibitor Nogo-A. The company was founded by Martin E. Schwab and Roger M. Nitsch and is headquartered in Schlieren, Switzerland.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Dominik Escher
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| NOVARTIS AG | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| SWISS LIFE HOLDING AG | Life/Health Insurance | Chief Executive Officer Director/Board Member | |
| VONTOBEL HOLDING AG | Investment Managers | Director/Board Member Director/Board Member | |
Credit Suisse AG
 Credit Suisse AG Investment ManagersFinance Credit Suisse AG is an investment management firm headquartered in Zurich, Switzerland. The firm was founded in 1856 and was acquired by UBS Group AG (SWX: UBSG) from Credit Suisse Group AG in 2023. Credit Suisse manages global and regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals worldwide. They also offer private banking and wealth management, investment banking, and corporate and business support services. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| ZURICH INSURANCE GROUP LTD | Multi-Line Insurance | Director/Board Member Director of Finance/CFO | |
| LIECHTENSTEINISCHE LANDESBANK AG | Major Banks | Chief Operating Officer Chairman Director/Board Member | |
| VP BANK AG | Major Banks | Chairman Corporate Officer/Principal Director/Board Member | |
| PALFINGER AG | Trucks/Construction/Farm Machinery | Chief Operating Officer Director/Board Member | |
| MORPHOSYS AG | Biotechnology | Chief Executive Officer Founder | |
SIX SIS Ltd.
 SIX SIS Ltd. Investment Banks/BrokersFinance SIX SIS Ltd. operates as the national central securities depository of the Swiss financial market and an international central securities depository. It offers services for the settlement and custody of national and international securities. The firm also operates an online real-time settlement system, which enables market participants to settle their transactions through a single technical interface. The company was founded on May 21, 1999 and is headquartered in Olten, Switzerland. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree | |
| École Polytechnique Fédérale de Lausanne | College/University | Undergraduate Degree Doctorate Degree | |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Masters Business Admin Corporate Officer/Principal Graduate Degree | |
| New York University | College/University | Graduate Degree Graduate Degree | |
| INSEAD | College/University | Director/Board Member Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| University of St. Gallen | College/University | Graduate Degree Masters Business Admin Masters Business Admin Undergraduate Degree | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Basel | College/University | Doctorate Degree Doctorate Degree | |
| University of Lausanne | College/University | Graduate Degree Graduate Degree | |
| International Institute for Management Development | College/University | Corporate Officer/Principal Masters Business Admin | |
| MOLECULAR PARTNERS AG | Biotechnology | Founder Director/Board Member | |
INSERM Transfert Initiative SAS
 INSERM Transfert Initiative SAS Investment ManagersFinance INSERM Transfert Initiative SAS is a venture capital fund that invests in companies located in France. It targets startups from the life sciences and biotechnology sectors, developing new medical practices with a strong intellectual property. It invests between €1 million and €3 million per company during mostly at pre-seed, seed and early-stages. | Investment Managers | Chairman Chairman | |
| LEONTEQ AG | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
SIX Group AG
 SIX Group AG Packaged SoftwareTechnology Services SIX Group AG engages in the development and operation of a central infrastructure, which ensures the flow of information and money between banks, traders, merchants, and investors. It offers products and services for securities trading, stock market transactions, financial information, and payment transactions. The company was founded in 1930 and is headquartered in Zurich, Switzerland. | Packaged Software | Director of Finance/CFO Director of Finance/CFO | |
Bellevue Asset Management (Venture Capital)
 Bellevue Asset Management (Venture Capital) Investment ManagersFinance Bellevue Asset Management (Venture Capital) is the venture capital arm of Bellevue Asset Management AG, a subsidiary of Bellevue Group AG (SW: BBN) headquartered in Zurich, Switzerland. The firm was founded in 1993. | Investment Managers | Private Equity Investor Private Equity Investor | |
SIX Financial Information AG
 SIX Financial Information AG Internet Software/ServicesTechnology Services SIX Financial Information Ltd. provides wealth and asset management services. It offers reference and market data, corporate actions, regulatory data and pricing information. The company was founded on October 23, 1930 and is headquartered in Zurich, Switzerland. | Internet Software/Services | Director/Board Member Director/Board Member | |
| JULIUS BÄR GRUPPE AG | Financial Conglomerates | Corporate Officer/Principal Chief Executive Officer | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Lucerne University of Applied Sciences & Arts | College/University | Corporate Officer/Principal Graduate Degree | |
Neurimmune Holding AG
 Neurimmune Holding AG Pharmaceuticals: MajorHealth Technology Neurimmune Holding AG is a Swiss pharmaceutical company that was founded in 2006. The private company is based in Schlieren, Switzerland and has subsidiaries in Switzerland. Neurimmune Holding manufactures pharmaceutical products. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Bank Julius Baer & Co. Ltd. (Hong Kong)
 Bank Julius Baer & Co. Ltd. (Hong Kong) Investment ManagersFinance Bank Julius Baer & Co. Ltd. (Hong Kong) (Julius Baer-Hong Kong) is the Hong Kong-based wealth management subsidiary of Bank Julius Baer & Co. AG, itself a subsidiary of Julius Bär Gruppe AG (SWX: BAER), a private banking corporation headquartered in Switzerland. Founded in 2010, Julius Baer-Hong Kong provides comprehensive investment advisory services. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Metabomed Ltd.
 Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| LYSOGENE | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member Director/Board Member | |
| ACTICOR BIOTECH SAS | Biotechnology | Director/Board Member Director/Board Member | |
AL-S Pharma AG
 AL-S Pharma AG Pharmaceuticals: MajorHealth Technology AL-S Pharma AG engages in the development and marketing of pharmaceutical products. The company was founded by Michael Salzmann on September 19, 2016 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BLACKSTONE RESOURCES AG | Precious Metals | Director of Finance/CFO Director/Board Member | |
Bank Julius Bär & Co. Ltd. /CH/
 Bank Julius Bär & Co. Ltd. /CH/ Major BanksFinance Part of Julius Bär Gruppe AG, Bank Julius Bär & Co. Ltd. is a banking company based in Zurich, Switzerland. The Swiss company provides banking services. Philipp Rickenbacher has been the CEO of the company since 2009. | Major Banks | Corporate Officer/Principal Chief Executive Officer | |
Incepto Medical SAS
 Incepto Medical SAS Packaged SoftwareTechnology Services Incepto Medical SAS develops and distributes artificial intelligent (AI) based medical imaging applications. It offers solutions for computed tomography (CT) scans, chest x-ray, and detections for conditions such as fracture and bowel occlusion. The company was founded by Antoine Jomier, Florence Moreau, Vincent Barrau, Jean Michel Malbrancq, and Gaspard d’Assignies and is headquartered in Paris, France. | Packaged Software | Director/Board Member Director/Board Member | |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Alentis Therapeutics AG
 Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Future Foundation of Liechtensteinische Landesbank AG | Director/Board Member Director/Board Member |
Statistik
International
| Schweiz | 28 |
| Frankreich | 10 |
| Liechtenstein | 4 |
| Vereinigte Staaten | 4 |
| Deutschland | 3 |
Sektoral
| Finance | 16 |
| Health Technology | 16 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Technology Services | 4 |
Operativ
| Director/Board Member | 416 |
| Corporate Officer/Principal | 180 |
| Chairman | 78 |
| Chief Executive Officer | 63 |
| Graduate Degree | 55 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Chahra Khaoua Epouse Louafi | 26 |
| Daniel Schmucki | 25 |
| Daniel Vasella | 25 |
| Claudio Nessi | 25 |
| François Thomas | 25 |
| Rafaèle Elisabeth Tordjman | 23 |
| Seymur Tari | 22 |
| Michael Halbherr | 22 |
| Patrick Frost | 21 |
| Martin C. Münchbach | 20 |
| Catherine Boule | 18 |
| Nicole Onetto | 17 |
| Arnd Kaltofen-Ehmann | 16 |
| Reto Suter | 16 |
| Klaus Breiner | 16 |
- Börse
- Insiders
- Dominik Escher
- Unternehmensverbindungen
